Neil Kumar

Chief Executive Officer, Director, BridgeBio Pharma, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$53.5M

Companies

Latest trade

Sep 17, 2026

Companies

BridgeBio Pharma, Inc.Chief Executive Officer, Director −$56.8M

Trades

BBIO Sold 10,000 shares at $69.08 · planned $0.7M Sep 17

BBIO Sold 10,000 shares at $84.03 · planned $0.8M Aug 19

BBIO Sold 34,980 shares at $82.53 · planned $2.9M Aug 18

BBIO Sold 31,563 shares at $67.87 · planned $2.1M Jun 5

BBIO Sold 20,000 shares at $67.46 · planned $1.3M Jun 4

BBIO Sold 26,103 shares at $69.44 · planned $1.8M May 21

BBIO Sold 39,050 shares at $66.87 · planned $2.6M May 8

BBIO Sold 40,000 shares at $67.90 · planned $2.7M May 7

BBIO Sold 20,000 shares at $74.60 · planned $1.5M Apr 10

BBIO Sold 40,000 shares at $74.61 · planned $3.0M Apr 9

BBIO Sold 40,000 shares at $68.80 · planned $2.8M Mar 13

BBIO Sold 39,700 shares at $68.72 · planned $2.7M Mar 12

BBIO Sold 28,053 shares at $71.39 · planned $2.0M Feb 19

BBIO Sold 40,000 shares at $71.78 · planned $2.9M Feb 11

BBIO Sold 40,000 shares at $71.94 · planned $2.9M Feb 10

BBIO Sold 40,000 shares at $77.11 · planned $3.1M Jan 9

BBIO Sold 40,000 shares at $73.97 · planned $3.0M Jan 8

BBIO Sold 30,011 shares at $74.64 · planned $2.2M Dec 15

BBIO Sold 40,000 shares at $73.31 · planned $2.9M Dec 5

BBIO Sold 37,900 shares at $74.46 · planned $2.8M Dec 4

BBIO Sold 26,156 shares at $65.84 · planned $1.7M Nov 20

BBIO Sold 40,000 shares at $61.43 · planned $2.5M Nov 7

BBIO Sold 39,900 shares at $63.15 · planned $2.5M Nov 6

BBIO Sold 20,000 shares at $54.80 · planned $1.1M Oct 9

BBIO Sold 40,000 shares at $54.79 · planned $2.2M Oct 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.